Subscribe for the Emerj "AI in Life Sciences Pulse" NewsletterLeaders at some of the world's most respected Life Sciences organizations subscribe to Emerj:
Trending Life Sciences Podcast Episodes
Trending AI in Life Sciences Content
AI has profound implications for drug discovery, ushering in a new era of innovation and efficiency. Recent milestones - such as the first AI-designed drug molecule to enter human clinical trials and the prediction of protein structures for millions of proteins - showcase the transformative power of AI in this domain.
Like many other economic and industrial sectors, AI is beginning to transform operations across life sciences. In a 2021 survey of life science organizations published by the International Data Corporation (IDC), respondents cited a 65% average increase in AI spending in their organizations over the next year.
The importance of AI in the pharmaceutical space has grown exponentially over the last few years, spearheaded by global demand for a COVID vaccine at the pandemic’s apex. Moreover, AI has proven helpful throughout the pandemic, all while providing glimpses into the future promise of the technology.
This article was originally written as part of a PDF report sponsored by expert.ai, and was written, edited and published in alignment with our transparent Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.